Literature DB >> 21224470

The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells.

Julia Testori1, Bernhard Schweighofer, Iris Helfrich, Caterina Sturtzel, Karoline Lipnik, Sabine Gesierich, Patrick Nasarre, Renate Hofer-Warbinek, Martin Bilban, Hellmut G Augustin, Erhard Hofer.   

Abstract

The HLX gene encoding a diverged homeobox transcription factor has been found to be up-regulated by vascular endothelial growth factor-A (VEGF-A) in endothelial cells. We have now investigated the gene repertoire induced by HLX and its potential biologic function. HLX strongly increased the transcripts for several repulsive cell-guidance proteins including UNC5B, plexin-A1, and semaphorin-3G. In addition, genes for transcriptional repressors such as HES-1 were up-regulated. In line with these findings, adenoviral overexpression of HLX inhibited endothelial cell migration, sprouting, and vessel formation in vitro and in vivo, whereas proliferation was unaffected. This inhibition of sprouting was caused to a significant part by HLX-mediated up-regulation of UNC5B as shown by short hairpin RNA (shRNA)-mediated down-modulation of the respective mRNA. VEGF-A stimulation of endothelial cells induced elevated levels of HLX over longer time periods resulting in especially high up-regulation of UNC5B mRNA as well as an increase in cells displaying UNC5B at their surface. However, induction of HLX was strongly reduced and UNC5B up-regulation completely abrogated when cells were exposed to hypoxic conditions. These data suggest that HLX may function to balance attractive with repulsive vessel guidance by up-regulating UNC5B and to down-modulate sprouting under normoxic conditions.
© 2011 by The American Society of Hematology

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21224470      PMCID: PMC3096761          DOI: 10.1182/blood-2010-07-293209

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation.

Authors:  Natallia Mikhalkevich; Brian Becknell; Michael A Caligiuri; Michael D Bates; Richard Harvey; Wei-ping Zheng
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

2.  Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction.

Authors:  Gayathri Rajaraman; Padma Murthi; Niroshani Pathirage; Shaun P Brennecke; Bill Kalionis
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 3.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.

Authors:  Marco Presta; Patrizia Dell'Era; Stefania Mitola; Emanuela Moroni; Roberto Ronca; Marco Rusnati
Journal:  Cytokine Growth Factor Rev       Date:  2005-02-02       Impact factor: 7.638

4.  Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.

Authors:  M Bilban; D Heintel; T Scharl; T Woelfel; M M Auer; E Porpaczy; B Kainz; A Kröber; V J Carey; M Shehata; C Zielinski; W Pickl; S Stilgenbauer; A Gaiger; O Wagner; U Jäger
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

5.  The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation.

Authors:  Bernhard Schweighofer; Julia Testori; Caterina Sturtzel; Susanne Sattler; Herbert Mayer; Oswald Wagner; Martin Bilban; Erhard Hofer
Journal:  Thromb Haemost       Date:  2009-09       Impact factor: 5.249

6.  Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.

Authors:  Guido Serini; Donatella Valdembri; Sara Zanivan; Giulia Morterra; Constanze Burkhardt; Francesca Caccavari; Luca Zammataro; Luca Primo; Luca Tamagnone; Malcolm Logan; Marc Tessier-Lavigne; Masahiko Taniguchi; Andreas W Püschel; Federico Bussolino
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

7.  Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator.

Authors:  J Wojta; R L Hoover; T O Daniel
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

8.  Homeobox gene HLX1 is a regulator of colony stimulating factor-1 dependent trophoblast cell proliferation.

Authors:  G Rajaraman; P Murthi; B Leo; S P Brennecke; B Kalionis
Journal:  Placenta       Date:  2007-05-25       Impact factor: 3.481

9.  Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts.

Authors:  Martin Bilban; Nassim Ghaffari-Tabrizi; Edith Hintermann; Sandra Bauer; Sylvia Molzer; Cristina Zoratti; Roland Malli; Andrew Sharabi; Ursula Hiden; Wolfgang Graier; Martin Knöfler; Fritz Andreae; Oswald Wagner; Vito Quaranta; Gernot Desoye
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

10.  Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.

Authors:  Dan Liu; Haiyan Jia; David Ian Roderick Holmes; Anita Stannard; Ian Zachary
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-02       Impact factor: 8.311

View more
  17 in total

Review 1.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

Authors:  Jonathan Welti; Sonja Loges; Stefanie Dimmeler; Peter Carmeliet
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

2.  ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.

Authors:  Bruno Larrivée; Claudia Prahst; Emma Gordon; Raquel del Toro; Thomas Mathivet; Antonio Duarte; Michael Simons; Anne Eichmann
Journal:  Dev Cell       Date:  2012-03-13       Impact factor: 12.270

3.  Endothelial RhoGEFs: A systematic analysis of their expression profiles in VEGF-stimulated and tumor endothelial cells.

Authors:  Ricardo Hernández-García; M Luisa Iruela-Arispe; Guadalupe Reyes-Cruz; José Vázquez-Prado
Journal:  Vascul Pharmacol       Date:  2015-10-17       Impact factor: 5.773

4.  Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.

Authors:  Jason E Fish; Manuel Cantu Gutierrez; Lan T Dang; Nadiya Khyzha; Zhiqi Chen; Shawn Veitch; Henry S Cheng; Melvin Khor; Lina Antounians; Makon-Sébastien Njock; Emilie Boudreau; Alexander M Herman; Alexander M Rhyner; Oscar E Ruiz; George T Eisenhoffer; Alejandra Medina-Rivera; Michael D Wilson; Joshua D Wythe
Journal:  Development       Date:  2017-05-23       Impact factor: 6.868

5.  An uncoordinated-5 homolog B receptor monoclonal antibody regulates A375 melanoma cell migration.

Authors:  Yuanling Zuo; Jianfeng Yang; Jun He; Yiming Zhao; Yang He
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08

6.  HOXA9 regulates angiogenesis in human hypertrophic scars: induction of VEGF secretion by epidermal stem cells.

Authors:  Peng-Fei Cao; Ying-Bin Xu; Jin-Ming Tang; Rong-Hua Yang; Xu-Sheng Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

7.  Analysis of the transcriptomes downstream of Eyeless and the Hedgehog, Decapentaplegic and Notch signaling pathways in Drosophila melanogaster.

Authors:  Landry E Nfonsam; Carlos Cano; Joann Mudge; Faye D Schilkey; Jennifer Curtiss
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

8.  The transcription factor MEF2C negatively controls angiogenic sprouting of endothelial cells depending on oxygen.

Authors:  Caterina Sturtzel; Julia Testori; Bernhard Schweighofer; Martin Bilban; Erhard Hofer
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

9.  Determination of endothelial stalk versus tip cell potential during angiogenesis by H2.0-like homeobox-1.

Authors:  Shane P Herbert; Julia Y M Cheung; Didier Y R Stainier
Journal:  Curr Biol       Date:  2012-08-23       Impact factor: 10.834

10.  Downregulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2.

Authors:  Yan Xu; Jingjing Gao; Zhaoliang Su; Xiaoli Dai; Yazhen Li; Yingzhao Liu; Jianguo Chen; Jia Tong; Yun Zhang; Chaoyang Wu; Dong Zheng; Shengjun Wang; Huaxi Xu
Journal:  Clin Dev Immunol       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.